Kui Yang
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Antifungal resistance and susceptibility 3
- Co-authors
- Jian Zuo (8 shared papers)Hui Jiang (5 shared papers)Jinbo Liu (7 shared papers)Zhangrui Zeng (5 shared papers)Yinhuan Ding (5 shared papers)Dexi Zhou (3 shared papers)Huifang Wang (1 shared paper)Yongjun Chen (2 shared papers)
- Journals
- Microbial Pathogenesis (2 papers)Medicine (2 papers)Chronobiology International (2 papers)Biomedicine & Pharmacotherapy (2 papers)BMC Infectious Diseases (2 papers)
- Partner nations
- ChinaThailandUnited States
In The Last Decade
Kui Yang
30 papers receiving 535 citations
Peers
Comparison fields: 5 of 94
- Hepatology 78
- Biological Psychiatry 18
- Neurology 47
- Immunology 99
- Molecular Medicine 22
Countries citing papers authored by Kui Yang
This map shows the geographic impact of Kui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kui Yang more than expected).
Fields of papers citing papers by Kui Yang
This network shows the impact of papers produced by Kui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kui Yang. The network helps show where Kui Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kui Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 71 | |
| 2 | 2018 | 60 | |
| 3 | 2017 | 43 | |
| 4 | 2019 | 37 | |
| 5 | 2017 | 30 | |
| 6 | 2017 | 26 | |
| 7 | 2017 | 24 | |
| 8 | 2023 | 23 | |
| 9 | 2020 | 22 | |
| 10 | 2018 | 21 | |
| 11 | 2016 | 21 | |
| 12 | 2019 | 20 | |
| 13 | 2021 | 18 | |
| 14 | 2020 | 16 | |
| 15 | 2019 | 15 | |
| 16 | 2021 | 14 | |
| 17 | 1995 | 12 | |
| 18 | 2020 | 9 | |
| 19 | 2018 | 9 | |
| 20 | 2020 | 9 |
About Kui Yang
Kui Yang is a scholar working on Molecular Biology, Infectious Diseases, Immunology, Oncology and Epidemiology, having authored 31 papers that have together received 538 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Circadian rhythm and melatonin (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Antifungal resistance and susceptibility (3 papers), Immune cells in cancer (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Hepatology (78 citations), Biological Psychiatry (18 citations), Neurology (47 citations), Immunology (99 citations) and Molecular Medicine (22 citations). Kui Yang has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Jian Zuo, Hui Jiang, Jinbo Liu, Zhangrui Zeng, Yinhuan Ding, Dexi Zhou, Huifang Wang, Yongjun Chen, Chenghong Peng and Ruo‐Yu Guan. Their work appears in journals such as Microbial Pathogenesis, Medicine, Chronobiology International, Biomedicine & Pharmacotherapy and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.